A股盘前播报 | 中东担忧缓解！原油、黄金跳水；创新药迎重磅利好

Industry Insights - The National Medical Products Administration of China has proposed to expedite the review and approval process for clinical trials of innovative drugs, aiming to complete reviews within 30 working days for eligible applications, which is expected to enhance the efficiency of clinical research [2] - The brain-computer interface technology is rapidly transitioning from laboratory to commercial applications in China, with significant growth potential, making it suitable for medium to long-term investment [8] - The quantum technology industry is projected to reach a valuation in the hundreds of billions, driven by policy support and industrialization efforts, with various applications being explored both domestically and internationally [10] Company Developments - Goldman Sachs has identified a group of ten leading private enterprises in China, including Tencent, Alibaba, and Xiaomi, which are expected to strengthen their market dominance, similar to the "Big Seven" in the US [3] - Circle's stock price surged by 13.1% to $151, nearing five times its IPO price, with a market capitalization exceeding $33.6 billion, highlighting the growing significance of its stablecoin USDC in the market [4] - Midea Group plans to repurchase shares worth between 5 billion to 10 billion yuan, indicating a positive outlook on its stock performance [11]